Impact of Screening Interval on CD4+ Counts at the Time of Human Immunodeficiency Virus Diagnosis
Catherine M Berjohn(Henry M. Jackson Foundation), Ryan C. Maves(Naval Medical Center San Diego), Robert Deiss, Octavio Mesner, Mary Bavaro, Brian K. Agan(Henry M. Jackson Foundation), Jason F. Okulicz, Tahaniyat Lalani(Henry M. Jackson Foundation)
Cited by 0
Related Papers
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
|The Lancet Respiratory Medicine|2022|128
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies
|Science Translational Medicine|2022|94
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection
|JAMA Network Open|2023|91